课题基金 / 基金详情

Strategy for hepatocellular carcinoma from the view point of viral status

Strategy for hepatocellular carcinoma from the view point of viral status
从病毒状态角度治疗肝细胞癌的策略
批准号:
09671330
负责人:
KUBO Shoji
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

KUBO Shoji的其他基金

相似基金

相关文献

中文摘要
翻译
在我科接受肝细胞癌(HCC)切除术的患者中,约97%的患者血清中检测到乙型肝炎和/或丙型肝炎病毒。1%的患者在HCC组织中检测到乙型肝炎病毒基因。213例患者中有12例血清检测到G型肝炎病毒RNA。12例患者血清中也有乙型肝炎病毒(HBV)或丙型肝炎病毒(HCV)标志物,表明G型肝炎病毒与HCC的相关性较差。HBV感染患者的年龄比HCV感染患者年轻。HBV感染患者的肿瘤大小大于HCV感染患者。在野生型HBV和大量HBV患者中,术后HBV含量有时升高,随后丙氨酸转氨酶活性升高。在感染HBV的患者中,复发的危险因素包括血小板计数低、野生型HBV、高病毒载量、手术切缘阳性和非自发切除。HCV感染患者的危险因素有:年龄大、血清HCV RNA阳性、丙氨酸和天冬氨酸转氨酶活性高、肿瘤大(大于4cm)、多发肿瘤、门静脉侵犯。肝细胞癌切除术后干扰素治疗可能有助于预防复发。延长切除(解剖切除)适用于感染HBV的患者。对于感染HCV的患者,不仅需要肝细胞癌的完全切除,还需要针对HCV的so策略。
英文摘要
Serum markers for Hepatitis B and/or C virus were detected in about 97% of patients who underwent liver resection for hepatocellular carcinoma (HCC) in our department. In 1 % of the patients, hepatitic B virus gene was detected in HCC tissue. Hepatitis G virus RNA was detected in sera in 12 of 213 patients. The 12 patients also had serum markers for hepatitis B virus (HBV) or hepatitis C virus (HCV), indicating that the hepatitis G virus has poor association with HCC.The age was younger in patients infected with HBV than in patients infected with HCV.The tumor size was larger in patients infected with HBV than in patients infected with HCV.The amount of HBV sometimes increased after operation, followed by increase in alanine aminotransferase activity, in patients with wild-type HBV and large amount of HBV.In patients infected with HBV, the risk factors for recurrence included low platelet count, wild-type HBV, high viral load, positive surgical margin, and nonantomic resection. In patients infected with HCV, the risk factors included high age, positive serum HCV RNA, high activities of alanine and aspartate aminotransferase, larged tumor size (more than 4cm), multiple tumors, and portal invasion. Interferon therapy after resection of HCC may be useful to prevent recurrence. Extended resection (anatomic resection) is indicated for patients infected with HBV.For patients infected with HCV, not only complete resection of HCC but a1so strategy for HCV are necessary.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shoji Kubo,et al.: "High prelalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan" Hepatogastroenteral. (in press).
Shoji Kubo 等人:“日本肝细胞癌患者中乙型和丙型肝炎病毒感染的高患病率”肝胃肠病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
首藤太一 他: "同時性多発肝細胞癌に対する手術用式とその成績" 日本外科系連合学会雑誌. 23(1). 69-74 (1998)
Taichi Shuto 等:“同步性多发性肝细胞癌的手术方案及其结果”,日本外科学会杂志 23(1) 69-74 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
久保正二 他: "肝炎ウイルス病態からみた肝細胞癌治療戦略" 消化器外科. 21(4). 425-430 (1998)
Shoji Kubo 等人:“从肝炎病毒病理学的角度治疗肝细胞癌”,《胃肠外科》21(4)425-430(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Identification of mechanism of hepatocarcinogenesis by analysi of microRNA
    • 批准号:
      23591994
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      KUBO Shoji
    • 依托单位:
    Mechanism of hepatocarcinogenesis in patients without infection of hepatitis B and C viruses by molecular biological analysis
    • 批准号:
      20591616
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.25万
    • 财政年份:
      2008
    • 负责人:
      KUBO Shoji
    • 依托单位:
    Constitution of a system of microarray CGH analysis for wide-screening and a research for genes responsible for hepatocellular carcinoma
    • 批准号:
      17591431
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.1万
    • 财政年份:
      2005
    • 负责人:
      KUBO Shoji
    • 依托单位:
    Mechanism of hepatocarcinogenesis by mitochondria DNA analysis and its clinical signifianoe
    海外基金